Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Oncología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Reclutando
ClinicalTrials.gov
Establishment and Exploitation of a European-Latin American Research Consortium Towards Eradication of Preventable Gallbladder Cancer - EULAT Eradicate GBC
OBSERVATIONAL
Inicio: 1 de dic de 2019
ID: NCT06192719
Reclutando
Fase 3
ClinicalTrials.gov
A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus Adjuvant Chemotherapy Versus Placebo Plus Adjuvant Chemotherapy in Stage IB-IIIA NSCLC Patients With Uncommon EGFR Mutations Following Complete Tumor Resection (REZILIENT4)
INTERVENTIONAL
Inicio: 22 de dic de 2025
ID: NCT07128199
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Previously Untreated, Locally Advanced, Inoperable or Metastatic Triple-Negative Breast Cancer Whose Tumors Do Not Express PD-L1 or in Patients Previously Treated With Anti-PD-(L)1 Agents in the Early Setting Whose Tumors Do Express PD-L1
INTERVENTIONAL
Inicio: 20 de jul de 2022
ID: NCT05382299
Completado
Fase 1
ClinicalTrials.gov
A Bioequivalence Study of Docetaxel for Injectable Emulsion (ANX-514) in Patients With Advanced Cancer
INTERVENTIONAL
Inicio: 1 de abr de 2008
ID: NCT00664170
Completado
ClinicalTrials.gov
Indicators of Sub-Optimal Response to Anti-Tumor Necrosis Factor (TNF) Therapy in Patients With Crohn's Disease (CD) and Ulcerative Colitis (UC): A Retrospective Chart Review in the Emerging Market (EM) Region (EXPLORE)
OBSERVATIONAL
Inicio: 28 de mar de 2017
ID: NCT03090139
Completado
Fase 2
ClinicalTrials.gov
A Phase 1b/2, Multicenter, Open-label Basket Study Evaluating the Safety and Efficacy of Bemarituzumab Monotherapy in Solid Tumors With FGFR2b Overexpression (FORTITUDE-301)
INTERVENTIONAL
Inicio: 23 de sept de 2022
ID: NCT05325866
Reclutando
Fase 3
ClinicalTrials.gov
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo As Maintenance Therapy After First Line Induction Therapy in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
INTERVENTIONAL
Inicio: 8 de sept de 2023
ID: NCT05894239
Completado
ClinicalTrials.gov
Evaluation of an mHealth Intervention Using an Automated Text Message (SMS) Invitation System to Increase Participation in Mammography Screening Among Women Aged 50-69 Years in the Province of Santa Fe, Argentina
INTERVENTIONAL
Inicio: 5 de dic de 2021
ID: NCT06500936
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Randomized, Double-blinded, Parallel Group, Multi-centre Study to Assess the Efficacy and Safety of ZD6474 (ZACTIMA™) in Combination With Pemetrexed (Alimta®) Versus Pemetrexed Alone in Patients With Locally-Advanced or Metastatic NSCLC
INTERVENTIONAL
Inicio: 1 de ene de 2007
ID: NCT00418886
Completado
Fase 2
ClinicalTrials.gov
A Randomized, Phase II, Multicenter, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Metmab Vs. Placebo in Combination With Either Bevacizumab + Platinum + Paclitaxel or Pemetrexed + Platinum in Patients With Untreated Stage IIIb or IV Non-Squamous NSCLC
INTERVENTIONAL
Inicio: 1 de abr de 2012
ID: NCT01496742
Reclutando
Fase 2
ClinicalTrials.gov
A Phase I/II Randomized Multi-Cohort Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 in Combination With Anti-Cancer Agents in Participants With Advanced Solid Tumors
INTERVENTIONAL
Inicio: 4 de mar de 2025
ID: NCT06796907
Completado
ClinicalTrials.gov
A Multicountry, Multicentre, Non-interventional, Prospective Study to Determine the Prevalence of EGFR Mutations in Patients With Early-stage, Surgically Resected, Non-squamous, Non-small Cell Lung Cancer
OBSERVATIONAL
Inicio: 4 de mar de 2021
ID: NCT04742192
Completado
Fase 3
ClinicalTrials.gov
Pivotal Study in Breast Cancer Patients Investigating Efficacy and Safety of LA-EP2006 and Neulasta®
INTERVENTIONAL
Inicio: 1 de mar de 2012
ID: NCT01516736
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Open-Label, Multicenter Clinical Study of CGT9486+Sunitinib vs. Sunitinib in Subjects With Locally Advanced, Unresectable, or Metastatic Gastrointestinal Stromal Tumors
INTERVENTIONAL
Inicio: 14 de abr de 2022
ID: NCT05208047
Completado
Fase 2
ClinicalTrials.gov
A Blinded, Randomized, Phase 1/2 Study of Brivanib Alaninate vs Placebo in Combination With Erbitux and Irinotecan K-Ras Wildtype Subjects With Metastatic Colorectal Cancer
INTERVENTIONAL
Inicio: 1 de may de 2008
ID: NCT00594984
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase III Randomized, Open-Label, Multi-Center, Global Study of MEDI4736 in Combination With Tremelimumab Therapy Versus Standard of Care Platinum-Based Chemotherapy in First-Line Treatment of Patients With Advanced or Metastatic Non Small-Cell Lung Cancer (NSCLC).
INTERVENTIONAL
Inicio: 3 de nov de 2015
ID: NCT02542293
Completado
Fase 3
ClinicalTrials.gov
A Randomized Placebo Controlled Study of OSI-774 (Erlotinib HCl, Tarceva[TM]) in Patients With Incurable Stage IIIB/IV Non-small Cell Lung Cancer Who Have Failed Standard Therapy for Advanced or Metastatic Disease
INTERVENTIONAL
Inicio: 1 de nov de 2001
ID: NCT00036647
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double Blind, Placebo Controlled, Multicenter Phase III Study of Regorafenib in Patients With Hepatocellular Carcinoma (HCC) After Sorafenib
INTERVENTIONAL
Inicio: 14 de may de 2013
ID: NCT01774344
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
INTERVENTIONAL
Inicio: 1 de mar de 2011
ID: NCT01234311
Completado
ClinicalTrials.gov
Biomarker Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer
OBSERVATIONAL
Inicio: 22 de abr de 2019
ID: NCT03871816
Anterior
1
...
65
66
67
...
434
Siguiente
Filtros